As digital transformation sweeps across sectors in Indonesia, healthcare is emerging as one of the most rapidly evolving areas. Spearheading this transformation is a new generation of Indonesia healthtech startups that are leveraging cutting-edge technologies to reshape how healthcare is delivered, accessed, and managed. With support from the Ministry of Health (Kementerian Kesehatan or Kemenkes), these startups are not only innovating but also integrating their services into the country’s official healthcare ecosystem.

This synergy between the public sector and private innovation is being facilitated through the Regulatory Sandbox Program, a strategic initiative by Kemenkes launched in January 2023. Designed as a controlled and monitored environment, the program enables health-focused startups to test, refine, and deploy their solutions under direct regulatory supervision.

For healthtech startups, the Regulatory Sandbox represents more than just compliance. It is a springboard to legitimacy, scale, and long-term integration within Indonesia’s national healthcare agenda.

Understanding the Regulatory Sandbox and Its Significance

The Regulatory Sandbox by Kemenkes offers a phased approach for startups to operate within the public health system. Startups admitted to the program receive regulatory guidance and oversight as they develop their services. If successful, they progress through three stages: “Tercatat” (Registered), “Diawasi” (Supervised), and “Dibina” (Mentored).

Each stage comes with increasing levels of integration and credibility. Companies that reach “Dibina” status can carry the official designation “Mentored by the Ministry of Health,” signaling public endorsement and heightened trust among patients and providers alike.

By partnering with Indonesia healthtech startups, Kemenkes is showing a commitment to innovation while ensuring these services align with the country’s medical, legal, and ethical standards.

Meet The Healthtech Innovators Backed By Kemenkes

Below are four standout healthtech startups that have officially partnered with Kemenkes through the Regulatory Sandbox. Each of these companies represents a different facet of digital healthcare, from telemedicine to AI-based genomics.

Getwell: Preventive Telemedicine and Digital Therapeutics

Getwell has positioned itself as a leader in preventive digital healthcare. Rather than focusing solely on curative solutions, Getwell emphasizes early detection and chronic disease management through its telemedicine platform.

One of its distinguishing features is the Digital Therapeutics (DTx) component, which helps patients manage long-term conditions like diabetes or hypertension with digital interventions. These include structured behavioral programs and remote monitoring tools.

The platform also gained prominence during the COVID-19 Omicron wave, when it was selected as one of 17 platforms endorsed by Kemenkes to provide remote isolation services for infected patients. Additionally, Getwell has achieved ISO 27001 certification for data security and partnered with Universitas Padjadjaran on chronic disease research.

The company is currently among the rising stars in the digital healthcare scene, championing both innovation and compliance.

Naluri: A Behavioral Science Approach From Malaysia

Naluri is a Malaysia-based startup that has successfully expanded into Indonesia and become one of the few foreign startups accepted into the Regulatory Sandbox. Naluri’s strength lies in its integrated approach to physical and mental health, combining digital tools with human intervention.

Its services include health tracking, coaching, and personalized care from a multidisciplinary team consisting of psychologists, nutritionists, and medical doctors. Using behavioral science as the foundation, Naluri provides targeted support for users managing chronic conditions like diabetes and hypertension.

In 2023, Naluri moved from the “Diawasi” phase to the “Dibina” phase, gaining the right to use the Kemenkes endorsement logo for one year. This marks a critical milestone in Naluri’s journey in Indonesia, signaling that its services are not only functional but also aligned with national health objectives.

Naluri’s model aligns well with the government's preventative health strategy, which aims to reduce the burden on hospitals by promoting early intervention and continuous care.

Asa Ren: Genomic Innovation For Personalized Healthcare

Founded in 2016, Asa Ren is pioneering genomics and AI-driven health insights in Indonesia. With over 2 million genomic data sets and hundreds of health-related variables, the company is driving advancements in personalized medicine and predictive diagnostics.

Asa Ren’s collaboration with Kemenkes and leading research institutions supports national efforts to implement precision medicine in Indonesia. By integrating genetic data into patient care, Asa Ren enables more accurate risk assessments and treatment pathways.

This is a major leap forward for Indonesia’s healthcare system, which traditionally follows a one-size-fits-all approach. Asa Ren is helping shift this paradigm by making healthcare personalized, data-driven, and forward-looking.

The company’s efforts not only enhance patient outcomes but also contribute to critical research and public health planning.

Cexup: White-Label Telemedicine and IoMT Integration

Cexup offers a white-label telemedicine platform, enabling hospitals and clinics to implement digital consultation services under their own brand. This flexibility makes Cexup a strategic partner for institutions aiming to modernize without building proprietary platforms from scratch.

Cexup also integrates IoMT (Internet of Medical Things) devices, such as tele-ECG, portable ultrasound, and remote patient monitoring tools. These devices enhance the scope of remote consultations and allow for more accurate diagnoses outside traditional clinical settings.

The startup entered the Regulatory Sandbox in 2023 and has already achieved “Diawasi” status. Notably, it has partnered with major institutions like RS UI and Pusdokkes Polri, bringing smart, scalable healthcare solutions to public institutions.

If Cexup progresses to the “Dibina” phase, it will join a select group of companies that have demonstrated strong potential to be adopted within national public health services.

Why This Matters: The Bigger Picture for Indonesian Healthcare

The rise of Indonesia healthtech startups is more than just a tech trend. It represents a structural shift in how healthcare will be accessed and delivered in the coming decades. Through the Regulatory Sandbox program, Kemenkes is doing more than regulating — it is co-creating the future of healthcare alongside innovators.

The benefits of this approach include:

• Faster innovation cycles for new technologies
• Regulatory certainty for startups entering a complex sector
• Greater public access to digital health tools
• Improved quality of care through data and personalization
• Reduced healthcare costs through prevention and early detection

Furthermore, these partnerships are helping local startups compete with global platforms, ensuring that innovation remains rooted in local contexts and addresses the specific needs of Indonesian communities.

By recognizing and nurturing these startups, Indonesia is setting an example for how public-private partnerships can drive meaningful change in healthcare.

Conclusion: A New Chapter for Healthtech in Indonesia

Indonesia’s healthcare landscape is undergoing a quiet revolution, driven in large part by its thriving ecosystem of healthtech innovators. Through the Regulatory Sandbox, Kemenkes is not only regulating but also mentoring and scaling up promising solutions that align with its vision for smart, accessible, and preventive healthcare.

As Getwell, Naluri, Asa Ren, and Cexup continue to grow under this program, their success will likely encourage more startups to enter the health sector, bringing with them fresh ideas, advanced technologies, and a shared goal of improving public health outcomes.

For now, these four startups stand at the forefront of Indonesia’s digital healthcare transformation — where innovation meets regulation, and tech meets care.